Comparing Press Ganey Holdings (PGND) and Simulations Plus (SLP)
Press Ganey Holdings (NYSE: PGND) and Simulations Plus (NASDAQ:SLP) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, analyst recommendations, institutional ownership, profitability and dividends.
Institutional & Insider Ownership
91.9% of Press Ganey Holdings shares are held by institutional investors. Comparatively, 32.1% of Simulations Plus shares are held by institutional investors. 5.1% of Press Ganey Holdings shares are held by company insiders. Comparatively, 36.9% of Simulations Plus shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
This table compares Press Ganey Holdings and Simulations Plus’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Press Ganey Holdings||8.69%||5.46%||3.34%|
Simulations Plus pays an annual dividend of $0.20 per share and has a dividend yield of 1.2%. Press Ganey Holdings does not pay a dividend. Simulations Plus pays out 62.5% of its earnings in the form of a dividend.
Volatility & Risk
Press Ganey Holdings has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Comparatively, Simulations Plus has a beta of -0.73, indicating that its share price is 173% less volatile than the S&P 500.
This is a summary of current recommendations and price targets for Press Ganey Holdings and Simulations Plus, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Press Ganey Holdings||0||0||0||0||N/A|
Earnings and Valuation
This table compares Press Ganey Holdings and Simulations Plus’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||NetIncome||Earnings Per Share||Price/Earnings Ratio|
|Press Ganey Holdings||N/A||N/A||N/A||$0.51||N/A|
|Simulations Plus||$19.97 million||14.25||$4.95 million||$0.32||51.60|
Simulations Plus has higher revenue and earnings than Press Ganey Holdings. Press Ganey Holdings is trading at a lower price-to-earnings ratio than Simulations Plus, indicating that it is currently the more affordable of the two stocks.
Simulations Plus beats Press Ganey Holdings on 6 of the 10 factors compared between the two stocks.
About Press Ganey Holdings
Press Ganey Holdings, Inc. is a provider of patient experience and caregiver measurement, performance analytics and strategic advisory solutions for healthcare organizations. The Company provides its clients with a digital platform that captures the perspectives of patients, physicians, nurses and other healthcare employees and enables its clients to benchmark, analyze and manage the patient and caregiver experience. Its solutions include Patient Experience Solutions, which include Patient experience measurement, insights and advisory services; Caregiver Engagement Solutions, which include Physician, nurse and employee engagement measurement, insights and advisory services; Clinical and Quality Solutions, which include nursing quality indicators, patient reported outcome measures, core measures and eMeasures, and Consulting Solutions, which include patient safety and care reliability, patient experience improvement, process flow, advanced analytics and insights and cultural alignment.
About Simulations Plus
Simulations Plus, Inc. (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour. MedChem Designer includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures. MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. DDDPlus simulates in-vitro laboratory experiments used to measure the rate of dissolution of the drug. GastroPlus simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs.
Receive News & Ratings for Press Ganey Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Press Ganey Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.